Side-by-side comparison of AI visibility scores, market position, and capabilities
Qualcomm-acquired (Oct 2025) open-source IoT microcontroller platform with $42-49M revenue; 30M+ users taught electronics with Arduino IDE and boards competing with Raspberry Pi in the $815M maker ecosystem.
Arduino is an Italian open-source electronics platform providing microcontroller development boards, the Arduino IDE programming environment, and a vast ecosystem of compatible shields, sensors, and libraries — enabling hobbyists, students, educators, engineers, and professional developers to prototype and build interactive electronic projects and IoT devices without deep embedded systems expertise. Founded in 2005 at the Interaction Design Institute Ivrea in Italy, Arduino built the most widely used prototyping platform in electronics education and maker culture, generating $42-49 million in revenue in 2024 from hardware sales, cloud services, and enterprise IoT solutions through arduino.cc. Qualcomm acquired Arduino in October 2025, integrating it into Qualcomm's IoT ecosystem.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.